Literature DB >> 24248475

Long-acting growth hormone.

Charlotte Höybye1, Jens Sandahl Christiansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24248475     DOI： 10.1007/s40272-013-0059-8

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN： 1174-5878            Impact factor:   3.022


× No keyword cloud information.
  23 in total

1.  Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD).

Authors:  Ferenc Péter; Martin Bidlingmaier; Conrad Savoy; Hyi-Jeong Ji; Paul H Saenger
Journal:  J Clin Endocrinol Metab       Date:  2011-12-07       Impact factor: 5.958

2.  Efficacy of a long-acting growth hormone (GH) preparation in patients with adult GH deficiency.

Authors:  Andrew R Hoffman; Beverly M K Biller; David Cook; Joyce Baptista; Bernard L Silverman; Le Dao; Kenneth M Attie; Paul Fielder; Thomas Maneatis; Barbara Lippe
Journal:  J Clin Endocrinol Metab       Date:  2005-09-13       Impact factor: 5.958

Review 3.  Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

Authors:  A Giustina; J D Veldhuis
Journal:  Endocr Rev       Date:  1998-12       Impact factor: 19.871

4.  Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline.

Authors:  Mark E Molitch; David R Clemmons; Saul Malozowski; George R Merriam; Mary Lee Vance
Journal:  J Clin Endocrinol Metab       Date:  2011-06       Impact factor: 5.958

5.  Pegylated long-acting human growth hormone possesses a promising once-weekly treatment profile, and multiple dosing is well tolerated in adult patients with growth hormone deficiency.

Authors:  Esben Søndergaard; Marianne Klose; Mette Hansen; Birgit Sehested Hansen; Marianne Andersen; Ulla Feldt-Rasmussen; Torben Laursen; Michael Højby Rasmussen; Jens Sandahl Christiansen
Journal:  J Clin Endocrinol Metab       Date:  2010-12-22       Impact factor: 5.958

Review 6.  Effects of growth hormone on glucose and fat metabolism in human subjects.

Authors:  Jens O L Jørgensen; Louise Møller; Morten Krag; Nils Billestrup; Jens S Christiansen
Journal:  Endocrinol Metab Clin North Am       Date:  2007-03       Impact factor: 4.741

7.  Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children.

Authors:  K W Kastrup; J S Christiansen; J K Andersen; H Orskov
Journal:  Acta Endocrinol (Copenh)       Date:  1983-10

8.  Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites.

Authors:  J O Jørgensen; N Møller; T Lauritzen; K G Alberti; H Orskov; J S Christiansen
Journal:  J Clin Endocrinol Metab       Date:  1990-01       Impact factor: 5.958

9.  Compliance and persistence in pediatric and adult patients receiving growth hormone therapy.

Authors:  Ron G Rosenfeld; Bert Bakker
Journal:  Endocr Pract       Date:  2008-03       Impact factor: 3.443

Review 10.  A review of guidelines for use of growth hormone in pediatric and transition patients.

Authors:  David M Cook; Susan R Rose
Journal:  Pituitary       Date:  2012-09       Impact factor: 3.599
View more
  3 in total

Review 1.  Long-Acting Growth Hormone Preparations - Current Status and Future Considerations.

Authors:  Bradley S Miller; Eric Velazquez; Kevin C J Yuen
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

Review 2.  Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogs.

Authors:  Kevin C J Yuen; Bradley S Miller; Cesar L Boguszewski; Andrew R Hoffman
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-24       Impact factor: 5.555

3.  The pharmacokinetic and pharmacodynamic properties and short-term outcome of a novel once-weekly PEGylated recombinant human growth hormone for children with growth hormone deficiency.

Authors:  Yan Liang; Cai Zhang; Haiyan Wei; Hongwei Du; Gaixiu Zhang; Yu Yang; Hua Zhang; Haihong Gong; Pin Li; Fuying Song; Zhuangjian Xu; Ruoyi He; Weidong Zhou; Heng Zheng; Li Sun; Xiaoping Luo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-11       Impact factor: 6.055
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.